Advisory Committees
-
Final Agenda for the November 15, 2010 Meeting of the Science Board to the FDA
Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814
| 8:30 a.m. | Introductions Barbara McNeil, M.D., Ph.D., Science Board Chair |
| 8:40 a.m. | Commissioner's Report Margaret Hamburg M.D., Commissioner of Food and Drugs |
| 9:00 a.m. | Q&A and Discussion |
| 9:15 a.m. | Science at the FDA Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health, Office of the Chief Scientist, Office of the Commissioner, FDA |
| 9:45 a.m. | Q&A and Discussion |
| 10:05 a.m. | BREAK |
| 10:20 a.m. | CFSAN evaluation and review of Subcommittee Final Review of Science at CFSAN Donald Zink, Ph.D., Senior Science Advisor, CFSAN |
| 11:00 a.m. | Q&A and Discussion |
| 11:15 a.m. | Medical Countermeasures Initiative and Regulatory Science Luciana Borio, M.D., Senior Advisor for Medicine and Public Health, Office of the Chief Scientist, Office of the Commissioner, FDA |
| 11:30 a.m. | Q&A and Discussion |
| 11:45 a.m. | Update: Subcommittee Review of Research at the Center for Drug Evaluation and Research (CDER), Pharmacovigilance Program Stephen Spielberg, M.D., Ph.D., Subcommittee Co-Chair and Science Board Member |
| 12:10 p.m. | Lunch (on your own) |
| 1:10 p.m. | Update: Subcommittee Review of Research at the Center for Drug Evaluation and Research (CDER), Pharmacovigilance Program (continued) Stephen Spielberg, M.D., Ph.D., Subcommittee Co-Chair and Science Board Member |
| 1:25 pm | Discussion: Comparative Effectiveness Research Plan Vicki Seyfert-Margolis, Ph.D., Senior Advisor for Science, Office of the Chief Scientist, Office of the Commissioner, FDA |
| 2:00 p.m. | Q&A and Discussion |
| 2:20 p.m. | Comments from the Science Board Chair Barbara McNeil, M.D., Ph.D., Science Board Chair |
| 2:30 p.m. | Adjourn |
-
-
